Novavax Announces COVID-19 Vaccine Clinical Development Progress

Go back to Novavax Announces COVID-19 Vaccine Clinical Development Progress
Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.00 -0.14 (1.72%)
Previous Close $8.14    52 Week High $9.23 
Open $8.13    52 Week Low $1.16 
Day High $8.13    P/E N/A 
Day Low $7.92    EPS $-0.30 
Volume 292,541       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 8.00 -0.14 (1.72%)
Previous Close $8.14    52 Week High $9.23 
Open $8.13    52 Week Low $1.16 
Day High $8.13    P/E N/A 
Day Low $7.92    EPS $-0.30 
Volume 292,541